Head and Neck Cancer Patients’ Quality of Life

Abstract

Patients suffering from head and neck cancers often require a multidisciplinary approach before and after surgery. Restoration of facial esthetics, speech, mastication and others often requires a long-lasting, divided rehabilitation. Quality of life (QOL) is measurable in a patient's life before and after surgery and complete treatment. The state of QOL has different parameters depending on the patient's clinical diagnosis, type of treatment and surgeries performed. In this paper, the authors are focusing on the quality of life of patients suffering from head and neck cancers and a proper multidisciplinary approach to achieving proper functions will be described. Also, the patient's self-esteem improvement and psychological evaluation is necessary (Adv Clin Exp Med 2014, 23, 6, 1019-1027).

Economic evaluation of a person-centred care intervention in head and neck oncology: results from a randomized controlled trial

“…physical functioning and nutrition [4]. An important aspect of such side effects are the challenges met by patient with HNC related to eating ability, weight loss and changed meaning of food [5], but the picture is further complicated by the large symptom burden identified also before treatment is initiated [6].…”

Social and medical determinants of quality of life and life satisfaction in women with Turner syndrome

“…Special and individual protocols should also be assessed in patients with TS. 19 The results of our research indicate that life satisfaction can be affected by both health-related and demographic variables. Our study revealed lower quality of life in those women with Turner syndrome who were troubled by their short statures, loneliness, feeling of being handicapped, and negative attitudes of other people.…”

Jak3 is involved in CCR7-dependent migration and invasion in metastatic squamous cell carcinoma of the head and neck

“…SCCHN, as a common malignant tumor of the head and neck, is characterized by a high degree of malignancy, high incidence of recurrence and metastasis, and high mortality. The combined treatment consisting of surgery or radiotherapy with postoperative adjuvant chemotherapy exhibits an improved outcome to prolong the overall survival in the treatment of SCCHN, but the prognosis remains far from optimistic due to the complexity and inscrutability of SCCHN (14,15). Development of novel effective therapeutic strategies is urgent to improve life quality and reduce quantity of patients with recurrent or metastatic SCCHN.…”